<DOC>
	<DOCNO>NCT00729755</DOCNO>
	<brief_summary>Given 1 ) establish safety short-term long-term supplementation Cr , 2 ) potential usefulness improve brain energy metabolism , 3 ) report abnormality brain energy metabolism MDD subject , 4 ) plausible association depression inflammatory mediator , hypothesize oral Cr augmentation help reduce symptom MDD patient well normalize deficit brain energy metabolism improvement MDD brain energy metabolism correlate inflammatory mediator change . In study , plan conduct randomize , double-blind , placebo-controlled augmentation study creatine addition escitalopram . We assess efficacy safety Cr augmentation evaluate change relevant brain energy metabolism inflammatory mediator .</brief_summary>
	<brief_title>Creatine Augmentation Treatment Major Depressive Disorder Subjects</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1965 yearold male female Major depressive disorder diagnose SCIDIV Hamilton depression rating scale score &gt; = 16 screen Written informed consent Suicidal idea need hospitalization Any axis I psychiatric disorder Neurologic disease ( eg. , epilepsy , infarct , multiple sclerosis , brain tumor ) IQ 80 Inflammatory disease include autoimmune disease Taking antiinflammatory medication Serious physical disease Substance abuse dependence history recent 6 month Pregnant plan pregnant</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Creatine</keyword>
	<keyword>Augmentation</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Brain Energy Metabolism</keyword>
</DOC>